Ångström AI
Ångström AI accelerates molecular simulation by leveraging generative AI to compute free energy differences, binding conformations, and hydration sites with ab initio accuracy. Their technology achieves orders of magnitude faster results than traditional simulations, using advanced machine learning models such as alchemically equipped MACE and equivariant generative model architectures. The company focuses on biomolecular free energy calculations with sub-chemical accuracy, enabling efficient and precise molecular modeling for scientific research and drug discovery. Their team includes experts in AI and computational chemistry, positioning Ångström AI as a cutting-edge player in computational molecular science.
Ångström AI
Ångström AI accelerates molecular simulation by leveraging generative AI to compute free energy differences, binding conformations, and hydration sites with ab initio accuracy. Their technology achieves orders of magnitude faster results than traditional simulations, using advanced machine learning models such as alchemically equipped MACE and equivariant generative model architectures. The company focuses on biomolecular free energy calculations with sub-chemical accuracy, enabling efficient and precise molecular modeling for scientific research and drug discovery. Their team includes experts in AI and computational chemistry, positioning Ångström AI as a cutting-edge player in computational molecular science.
TL;DR
What they do: Generative AI for molecular simulation to compute free energy differences, binding conformations, and hydration sites with near ab initio accuracy
Headquarters: San Francisco, California
Stage / funding: Pre-Seed; reported ~$500,000 total funding
Founding year: 2024
Company Overview
Problem Domain
Computational molecular simulation and pre-clinical drug discovery
Founded
2024
Industry
Biotechnology
Tech Stack
Funding Track Record
500000
Investors reported include Pioneer Fund, Rebel Fund, Unpopular Ventures, and Y Combinator
Investor Signal
“Pioneer Fund; Rebel Fund; Unpopular Ventures; Y Combinator”